Procedure for Maintaining Regulatory Compliance in Aerosol Product Development
| Department | Aerosol |
|---|---|
| SOP No. | SOP/Aerosol/176/2025 |
| Supersedes | SOP/Aerosol/176/2022 |
| Page No. | Page 1 of Y |
| Issue Date | 06/02/2025 |
| Effective Date | 16/02/2025 |
| Review Date | 06/02/2028 |
1. Purpose
The purpose of this Standard Operating Procedure (SOP) is to establish a systematic approach for ensuring regulatory compliance during the development of aerosol products. This SOP helps maintain adherence to regulatory standards, ensuring product safety, efficacy, and compliance with national and international guidelines.
2. Scope
This SOP applies to all aerosol product development activities, including formulation, stability studies, packaging, and labeling, ensuring compliance with FDA, EU GMP, and local regulatory authorities.
3. Responsibilities
- Regulatory Affairs Team: Responsible for ensuring compliance with local and international regulations.
- R&D Team: Responsible for developing formulations as per regulatory requirements.
- Quality Assurance (QA) Team: Responsible for verifying compliance at each development stage.
- Manufacturing Team: Responsible for implementing changes to meet updated regulatory standards.
4. Accountability
The Regulatory Affairs Head is accountable for ensuring that all product development processes comply with applicable regulations.
5. Procedure
5.1. Identifying Applicable Regulatory Standards
- Review and document all applicable regulatory guidelines, including:
- Good Manufacturing Practice (GMP)
- U.S. FDA Aerosol Regulations
- European Medicines Agency (EMA) Guidelines
- ISO Standards for Aerosol Products
- Record all regulatory requirements in the Compliance Requirements Log (Annexure-1).
5.2. Compliance in Formulation Development
- Ensure all raw materials comply
with pharmacopeial standards (USP, BP, IP).
Maintain complete records of ingredient safety data in the Formulation Compliance Log (Annexure-2).
5.3. Stability and Safety Testing Compliance
- Conduct stability studies as per ICH guidelines.
- Ensure safety evaluations meet regulatory requirements for toxicity, spray performance, and propellant safety.
- Document results in the Stability Testing Log (Annexure-3).
5.4. Compliance in Packaging and Labeling
- Verify that labeling follows regulatory mandates for hazard warnings, active ingredients, and batch coding.
- Ensure that packaging complies with environmental regulations (recyclability, propellant safety).
- Maintain records in the Labeling Compliance Log (Annexure-4).
5.5. Regulatory Submissions and Approvals
- Prepare dossiers for regulatory submission, including:
- Manufacturing process documentation
- Clinical and non-clinical study data
- Quality control and stability testing reports
- Track submission and approval statuses in the Regulatory Submission Log (Annexure-5).
6. Abbreviations
- GMP: Good Manufacturing Practice
- QA: Quality Assurance
- FDA: Food and Drug Administration
- ICH: International Council for Harmonisation
- EMA: European Medicines Agency
7. Documents
- Compliance Requirements Log (Annexure-1)
- Formulation Compliance Log (Annexure-2)
- Stability Testing Log (Annexure-3)
- Labeling Compliance Log (Annexure-4)
- Regulatory Submission Log (Annexure-5)
8. References
- Good Manufacturing Practice (GMP) Guidelines
- FDA Guidelines for Aerosol Products
- ICH Q1A Stability Testing Guidelines
9. SOP Version
Version: 2.0
10. Approval Section
| Prepared By | Checked By | Approved By | |
|---|---|---|---|
| Signature | |||
| Date | |||
| Name | |||
| Designation | |||
| Department |
11. Annexures
Annexure-1: Compliance Requirements Log
| Regulation | Requirement | Applicable Area | Compliance Status |
|---|---|---|---|
| FDA | Labeling requirements | Packaging | Compliant |
Annexure-2: Formulation Compliance Log
| Ingredient | Regulatory Standard | Compliance Status |
|---|---|---|
| Propellant A | USP | Compliant |
Annexure-3: Stability Testing Log
| Batch No. | Test Type | Test Date | Results |
|---|---|---|---|
| BN-123 | Accelerated Stability | 06/02/2025 | Passed |
Annexure-4: Labeling Compliance Log
| Label Type | Regulatory Requirement | Compliance Status |
|---|---|---|
| Warning Label | FDA 21 CFR 801 | Compliant |
Annexure-5: Regulatory Submission Log
| Submission ID | Regulatory Body | Submission Date | Approval Status |
|---|---|---|---|
| SUB-001 | FDA | 05/02/2025 | Pending |
12. Revision History:
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
|---|---|---|---|---|
| 01/01/2024 | V 1.0 | Initial Release | First Issue | Anjali Sharma |
| 01/01/2025 | V 2.0 | Updated regulatory requirements | GMP Compliance | Anjali Sharma |